BACKGROUND Nanotechnology involves the engineering of structures on a molecular
level. Nanomedicine and nano-delivery systems have been designed to deliver therapeutic …

The treatment of women's health-related conditions, including reproductive tract and
pregnancy disorders, faces distinct challenges and microenvironments, such as the vaginal …

Rationale: The availability of therapeutics to treat pregnancy complications is severely
lacking, mainly due to the risk of harm to the fetus. In placental malaria, Plasmodium …

Preterm birth (PTB) remains the leading cause of infant morbidity and mortality. Despite 50
years of research, therapeutic options are limited and many lack clear efficacy. Tocolytic …

While there is not a wide range of pregnancy-specific drugs, there are some very specific
high-risk areas of obstetric care for which unique pharmacological approaches have been …

Minimizing exposure of the fetus to medication and reducing adverse off-target effects in the
mother are the primary challenges in developing novel drugs to treat pregnancy …

In brief Preterm birth is the leading cause of perinatal morbidity and mortality; however,
current therapies offer limited efficacy to delay birth and improve neonatal outcomes. This …

Maternal mortality rates in the United States have steadily increased since 1987 to the
current rate of over 16 deaths per 100,000 live births. Whereas most of these deaths are …

Background: Preterm birth is the major cause of perinatal mortality and morbidity worldwide.
Attempts to reduce the burden may be proactive using biochemical or biophysical prediction …

Nanotechnology, the art of engineering structures on a molecular level, offers the
opportunity to implement new strategies for the diagnosis and management of pregnancy …